Brief: Epigenomics: draft registration statement for potential U.S. public offering of ADSs
10/08/2016 06:00
Aug 10 (Reuters) - Epigenomics AG ECXn.DE :
* Confidentially submits draft registration statement for potential U.S. public offering of
American Depositary Shares (ADSs)
Source text for Eikon: ID:nEQ1TtJyba
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns